524 related articles for article (PubMed ID: 27832151)
1. Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine-Burkina Faso, 2011-2013.
Kambiré D; Soeters HM; Ouédraogo-Traoré R; Medah I; Sangare L; Yaméogo I; Sawadogo G; Ouédraogo AS; Hema-Ouangraoua S; McGee L; Srinivasan V; Aké F; Congo-Ouédraogo M; Sanou S; Ba AK; Novak RT; Van Beneden C;
PLoS One; 2016; 11(11):e0166384. PubMed ID: 27832151
[TBL] [Abstract][Full Text] [Related]
2. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis, Burkina Faso, 2016-2017.
Soeters HM; Kambiré D; Sawadogo G; Ouédraogo-Traoré R; Bicaba B; Medah I; Sangaré L; Ouédraogo AS; Ouangraoua S; Yaméogo I; Congo-Ouédraogo M; Ky Ba A; Aké F; Srinivasan V; Novak RT; McGee L; Whitney CG; Van Beneden C
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S253-S262. PubMed ID: 31671444
[TBL] [Abstract][Full Text] [Related]
3. Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis-Burkina Faso, 2014-2015.
Kambiré D; Soeters HM; Ouédraogo-Traoré R; Medah I; Sangaré L; Yaméogo I; Sawadogo G; Ouédraogo AS; Ouangraoua S; McGee L; Srinivasan V; Aké F; Congo-Ouédraogo M; Ky Ba A; Whitney CG; Novak RT; Van Beneden C;
J Infect; 2018 Mar; 76(3):270-279. PubMed ID: 29253559
[TBL] [Abstract][Full Text] [Related]
4. Incidence, seasonality, age distribution, and mortality of pneumococcal meningitis in Burkina Faso and Togo.
Traore Y; Tameklo TA; Njanpop-Lafourcade BM; Lourd M; Yaro S; Niamba D; Drabo A; Mueller JE; Koeck JL; Gessner BD
Clin Infect Dis; 2009 Mar; 48 Suppl 2():S181-9. PubMed ID: 19191614
[TBL] [Abstract][Full Text] [Related]
5. Characterization of pneumococcal meningitis before and after introduction of 13-valent pneumococcal conjugate vaccine in Niger, 2010-2018.
Ousmane S; Kobayashi M; Seidou I; Issaka B; Sharpley S; Farrar JL; Whitney CG; Ouattara M
Vaccine; 2020 May; 38(23):3922-3929. PubMed ID: 32327220
[TBL] [Abstract][Full Text] [Related]
6. Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine.
Bozio CH; Abdul-Karim A; Abenyeri J; Abubakari B; Ofosu W; Zoya J; Ouattara M; Srinivasan V; Vuong JT; Opare D; Asiedu-Bekoe F; Lessa FC
PLoS One; 2018; 13(9):e0203205. PubMed ID: 30192772
[TBL] [Abstract][Full Text] [Related]
7. Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children ˂5 years in Cameroon, 2011-2018.
Njuma Libwea J; Fletcher MA; Koki Ndombo P; Boula A; Ashukem NT; Ngo Baleba M; Kingue Bebey RS; Nkolo Mviena EG; Tageube J; Kobela Mbollo M; Koulla-Shiro S; Madhi S; Njanpop-Lafourcade BM; Mohammad A; Begier E; Southern J; Beavon R; Gessner B
PLoS One; 2021; 16(4):e0250010. PubMed ID: 33857235
[TBL] [Abstract][Full Text] [Related]
8. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing.
Parent du Châtelet I; Traore Y; Gessner BD; Antignac A; Naccro B; Njanpop-Lafourcade BM; Ouedraogo MS; Tiendrebeogo SR; Varon E; Taha MK
Clin Infect Dis; 2005 Jan; 40(1):17-25. PubMed ID: 15614687
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal serotype distribution among meningitis cases from Togo and Burkina Faso during 2007-2009.
Gessner BD; Sanou O; Drabo A; Tamekloe TA; Yaro S; Tall H; Moïsi JC; Mueller JE; Njanpop-LaFourcade BM
Vaccine; 2012 Dec; 30 Suppl 6():G41-5. PubMed ID: 23228357
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of pneumococcal meningitis clusters in Burkina Faso and implications for potential reactive vaccination.
Soeters HM; Kambiré D; Sawadogo G; Ouédraogo-Traoré R; Bicaba B; Medah I; Sangaré L; Ouédraogo AS; Ouangraoua S; Yaméogo I; Congo-Ouédraogo M; Ky Ba A; Aké F; Velusamy S; McGee L; Van Beneden C; Whitney CG
Vaccine; 2020 Jul; 38(35):5726-5733. PubMed ID: 32591290
[TBL] [Abstract][Full Text] [Related]
11. The Global Landscape of Pediatric Bacterial Meningitis Data Reported to the World Health Organization-Coordinated Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2014-2019.
Nakamura T; Cohen AL; Schwartz S; Mwenda JM; Weldegebriel G; Biey JNM; Katsande R; Ghoniem A; Fahmy K; Rahman HA; Videbaek D; Daniels D; Singh S; Wasley A; Rey-Benito G; de Oliveira L; Ortiz C; Tondo E; Liyanage JBL; Sharifuzzaman M; Grabovac V; Batmunkh N; Logronio J; Heffelfinger J; Fox K; De Gouveia L; von Gottberg A; Du Plessis M; Kwambana-Adams B; Antonio M; El Gohary S; Azmy A; Gamal A; Voropaeva E; Egorova E; Urban Y; Duarte C; Veeraraghavan B; Saha S; Howden B; Sait M; Jung S; Bae S; Litt D; Seaton S; Slack M; Antoni S; Ouattara M; Van Beneden C; Serhan F
J Infect Dis; 2021 Sep; 224(12 Suppl 2):S161-S173. PubMed ID: 34469555
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany.
Imöhl M; Möller J; Reinert RR; Perniciaro S; van der Linden M; Aktas O
BMC Infect Dis; 2015 Feb; 15():61. PubMed ID: 25885764
[TBL] [Abstract][Full Text] [Related]
13. Determination of pneumococcal serotypes in meningitis cases in Niger, 2003-2011.
Collard JM; Alio Sanda AK; Jusot JF
PLoS One; 2013; 8(3):e60432. PubMed ID: 23555971
[TBL] [Abstract][Full Text] [Related]
14. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children.
Ruiz-Contreras J; Picazo J; Casado-Flores J; Baquero-Artigao F; Hernández-Sampelayo T; Otheo E; Méndez C; Del Amo M; Balseiro C;
Vaccine; 2017 Aug; 35(35 Pt B):4646-4651. PubMed ID: 28711388
[TBL] [Abstract][Full Text] [Related]
15. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
Mokaddas E; Albert MJ
Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
[TBL] [Abstract][Full Text] [Related]
16. Pediatric Bacterial Meningitis Surveillance in Niger: Increased Importance of Neisseria meningitidis Serogroup C, and a Decrease in Streptococcus pneumoniae Following 13-Valent Pneumococcal Conjugate Vaccine Introduction.
Kourna Hama M; Khan D; Laouali B; Okoi C; Yam A; Haladou M; Worwui A; Ndow PS; Nse Obama R; Mwenda JM; Biey J; Ntsama B; Kwambana-Adams BA; Antonio M
Clin Infect Dis; 2019 Sep; 69(Suppl 2):S133-S139. PubMed ID: 31505636
[TBL] [Abstract][Full Text] [Related]
17. Burden of Pneumococcal Disease in Northern Togo before the Introduction of Pneumococcal Conjugate Vaccine.
Moïsi JC; Makawa MS; Tall H; Agbenoko K; Njanpop-Lafourcade BM; Tamekloe S; Amidou M; Mueller JE; Gessner BD
PLoS One; 2017; 12(1):e0170412. PubMed ID: 28114427
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal Carriage in Burkina Faso After 13-Valent Pneumococcal Conjugate Vaccine Introduction: Results From 2 Cross-sectional Population-Based Surveys.
Kaboré L; Adebanjo T; Njanpop-Lafourcade BM; Ouangraoua S; Tarbangdo FT; Meda B; Velusamy S; Bicaba B; Aké F; McGee L; Yaro S; Betsem E; Gervaix A; Gessner BD; Whitney CG; Moïsi JC; Van Beneden CA
J Infect Dis; 2021 Sep; 224(12 Suppl 2):S258-S266. PubMed ID: 34469552
[TBL] [Abstract][Full Text] [Related]
19. The Burden of Invasive Bacterial Disease and the Impact of 10-Valent Pneumococcal Conjugate Vaccine in Children <5 years hospitalized for Meningitis in Lusaka, Zambia, 2010-2019.
Yamba K; Mpabalwani E; Nakazwe R; Mulendele E; Weldegebriel G; Mwenda JM; Katsande R; de Gouveia L; Chizema-Kawesha E; Chanda R; Matapo B; Mwansa JCL; Lukwesa-Musyani C
J Infect Dis; 2021 Sep; 224(12 Suppl 2):S275-S284. PubMed ID: 34469553
[TBL] [Abstract][Full Text] [Related]
20. Temporal trends and clonal diversity of penicillin non-susceptible pneumococci from meningitis cases from 1996 to 2012, in Salvador, Brazil.
dos Santos MS; Azevedo J; Menezes AP; Cordeiro SM; Escobar EC; Lima JB; Campos LC; Carvalho Mda G; Reis MG; Ko AI; Reis JN
BMC Infect Dis; 2015 Jul; 15():302. PubMed ID: 26223380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
